Twenty years of hard work and a hundred years of road to start the journey again
Release time:
2020-08-14
二十年砥砺奋进 百年路再启征程
——浙江尖峰药业有限公司成立20周年回望
1998年12月31日,作为从水泥行业起家的上市公司尖峰集团跨行业发展的重要成果——浙江尖峰药业有限公司注册成立了。经过整整20年的艰苦创业和拼搏发展,截止目前,尖峰药业总资产达到14.93亿元,拥有下属全资、控股和参股药品生产企业7家、药品经营企业3家、国家级博士后科研工作站4家、省级院士专家工作站2家,拥有国际、国内药品发明专利52项,主导产品市场占有率排名前3。公司先后多次获评全国医药百强企业、浙江省医药工业十强企业、国家重点高新技术企业、国家知识产权示范企业,浙江省创新型示范企业、浙江省专利示范企业、浙江省“‘守合同,重信用’AAA企业”等系列荣誉,“尖峰”商标被认定为中国驰名商标。尖峰药业已经成为浙江省乃至全国有一定规模和影响力的综合性医药企业。
科技创新结硕果
新药开发是医药企业的龙头与生命。秉承“科技造就健康”的理念,从成立开始,尖峰药业便极为重视新药的开发工作,投入巨资与国内各大科研院所紧密合作,取得系列成果。
2000年3月,尖峰药业开发研制的第一只新药克拉霉素胶囊顺利获得生产批文,6月正式生产投放市场。
2000年12月,尖峰药业和中国药科大学联合研制开发的我国第一个沙星类国家一类新药加替沙星,获国家临床公告保护,保护期为12年,同时被列为省、市重大科技攻关项目。2003年1月,加替沙星正式投放市场,并被列入国家高技术产业化示范工程项目;2004年被授予“国家重点新产品”称号;2006年获得浙江省科技进步一等奖。
2002年8月,尖峰药业开发的国家级新药愈风宁心滴丸获准国内首家上市,填补了浙江省这一剂型的空白。
2002年10月,尖峰药业开发的心血管类抗高血压一线药物力斯得(门冬氨酸氨氯地平片)正式上市。
2004年5月,尖峰药业研制开发的第三代抗抑郁药舒坦罗(帕罗西汀)正式上市。
2004年8月,尖峰药业注射用盐酸头孢甲肟、甘油果糖注射液两个新药成功取得生产批文。10月,第三代半合成的头孢菌素类广谱抗生素——注射用盐酸头孢甲肟在国内首仿上市,长期占据了国内同类产品50%以上的市场份额。
2007年9月4日,尖峰药业研制开发的国内首家产品国家二类新药带状疱疹特效药——注射用喷昔洛韦获得国家药监局批准生产,并于2008年1月全球首家上市销售。
2009年2月,尖峰药业研制开发的又一国家级新药醋氯芬酸缓释片取得新药证书和生产批文,为国内独家剂型。
2017年3月,尖峰药业主持研发的国家一类新药注射用去氧鬼臼毒素取得临床试验批件,目前正由中国医学科学院肿瘤医院牵头,在全国各大医院开展临床试验。
……
在开发了众多新药、取得诸多科技创新成果的同时,尖峰药业公司和个人也取得了一系列荣誉。
尖峰药业于2002年8月被认定为金华市高新技术企业;2003年6月被认定浙江省高新技术企业;2007年10月通过国家火炬计划重点高新技术企业复审,成为国家级重点高新技术企业,此后连续四次通过高新技术企业认定;2011年9月获“浙江省创新型示范企业”称号、入围“中国医药工业企业百强”。集团董事长兼药业公司董事长蒋晓萌在2005年荣获国务院特殊津贴,2013年荣获“浙江省有突出贡献中青年专家”称号。集团副总经理、药业公司总经理黄金龙在2011年获 “浙江省优秀科技工作者”荣誉称号,2015年获“全国优秀科技工作者”荣誉称号。
在进行新药开发与科技创新的过程中,尖峰药业与相关高校、医药科研单位展开了广泛合作,成立了省级新药研究开发中心,与上海医药工业研究院、中国药科大学、四川抗菌素工业研究所、浙江工业大学、金华职业技术学院等单位建立了良好的合作关系,进行产学研的全面合作,并取得了双赢共利的可喜成果。
产能扩充壮实力
尖峰药业成立之初,是通过兼并收购临海制药厂、浙江金华生物化学制药厂,合资组建浙江迪耳江南分厂等进行药品生产的。在自主开发新药取得成果的同时,自建、扩建生产基地,增加企业产能和规模便提上日程。
2001年7月13日,尖峰药业秋滨制药基地项目破土动工,于2002年12月13日通过国家GMP认证,是当时华东地区最大的单体药厂。
2001年12月21日,尖峰药业江南制药厂综合制剂大楼扩建的三个车间、五种剂型通过国家GMP认证。
此后十多年的时间里,两个制药厂又历经了多次改、扩、建,仍不能满足尖峰药业日益增长的与销售相匹配的产能需求,新建一个全新的、更大规模的制造基地便提上了议事日程。
2012年7月31日,尖峰药业金西生产基地项目破土动工。经过近三年的建设,2015年6月,原江南厂全部搬迁完毕。6月15日,金西厂综合制剂车间开始投料生产。7月8日,首批产品醋氯芬酸缓释片离厂发货。从此,尖峰药业有了在浙江省乃至全国领先的、拥有一流制造设备和环境的、全新的大规模药品生产制造基地。
2018年8月3日,集团公司董事会又批准尖峰药业金西基地年产20亿片固体制剂项目投资计划,将面向欧盟和美国等国际市场出口药品,走向国际化发展道路。
随着尖峰药业制造规模和产能的扩大,很快确立了在医药行业的地位,早在2000年就被评为“浙江省十佳工业企业”和“浙江省医药工业十强企业”;2003年又名列“全国医药百强企业”;2008年名列全国医药企业总产值第34位;2010年和2011年,两度入选“中国医药工业百强企业”;2013年入选“中国医药行业十大最具成长力企业”……一个成熟的、高素质的现代医药企业迅速展现在世人面前,并在中国医药行业拥有了较高的知名度和影响力。
多元销售展新貌
产品营销关乎企业的生存。尖峰药业从成立开始,就有计划、有步骤地不断进行营销模式的整合,实现资源的优化配置,充分发挥各个企业的优势,从而扬长避短,协调发展,齐头并进。
从1998年注册成立,尖峰药业便下大力气组建自身工业产品的销售队伍,在全国各省市建立办事处,大力拓展药品代理和终端业务市场,销售规模、总额、利润不断上升。除此之外,像盐酸头孢甲肟、盐酸胺碘酮、吗替麦考等产品则采用了全国业务总代理的销售模式,也取得了相当不错的销售业绩。
1999年,金华市医药商业系统进行了有史以来最大的一次资产重组,尖峰药业公司联合尖峰集团以2208万元一次性买断金华市医药公司的全部资产。曾经是金华地区唯一的医药批发企业的金华市医药公司,从此成为尖峰药业的下属企业,专门从事医药商业批发业务。兼并整合之后,金华市医药公司以其全流通、高周转的业务模式,为尖峰药业迅速扩大整体销售规模、提升销售总额做出了重要贡献。
2001年,尖峰药业在原金华市医药公司下属零售药店的基础上注册成立尖峰大药房连锁有限公司,建立起以金华市区为中心,辐射周边县、市、乡镇的药品零售网络。自成立以来,尖峰大药房以其高质量、周到服务的零售模式迅速发展成为金华药品零售的领头企业之一,随着国家处方权的放开,将进一步发展壮大。这对扩大尖峰品牌影响、社会知名度起到了重要作用。
在多种销售齐头并进的良好格局之下,尖峰药业的销售规模迅速扩大。2008年名列中国化学制药工业协会医药工业企业产品销售收入排名第31位和利润总额排名第54位。2010年荣获由《医药观察家报》评选的“最具成就企业奖”。2016年和2018年两度荣获“最具品牌价值奖”。
联合兼并拓规模
尖峰药业从成立之初,便打破地域的限制,对外进行投资,借助外地的技术和人才资源,迅速扩大公司规模,提升公司技术水平。
1999年,尖峰药业在天津投资100万元组建成立高新技术企业——天津市尖峰天然产物研究开发公司,专业从事植物提取物的技术研究和产品开发,多项产品出口国际市场,现已成为国内植物提取物行业的领军企业,提取物联盟的理事长单位,主持制定了多项植物提取的技术标准,取得了良好的经济效益和社会效益。后来在天津又投资了天津尖峰弗兰德医药技术公司。
2016年,尖峰药业控股成立中德合资浙江金得尔儿婴药品有限公司(尔婴公司),以此为基础,引进德国技术和产品,进军婴幼儿药品市场。
2017年,尖峰药业与相关各方签订《关于北京慧宝源生物技术股份有限公司之增资和股份转让协议》,分四期投资,以北京慧宝源生物技术股份有限公司及其控股子公司广西慧宝源生物技术有限公司为平台,共同合作开展新药研发、药品生产经营等医药业务合作。
2018年1月,尖峰药业与相关各方签订了系列协议,通过收购股份和增效的方式对上海北卡医药技术有限公司进行投资,以上海北卡及其子公司为平台,建立原料药和中间体的研发、生产基地,进一步延伸并完善产业链,增加产业规模,提高研发能力,为尖峰药业原料药生产提供可靠保障。8月,集团公司董事会批准尖峰药业公司对上海北卡医药公司进行增资、尖峰药业下属上海北卡医药公司收购安徽众望制药公司两项投资计划,尖峰药业版图再次扩张。
通过近二十年的对外投资、兼并、整合,尖峰药业建立了一条从上游原料药到下游制剂产品的完整产业链,并借助外地大城市企业的技术和人才优势,建立了一个巨大的合作共赢的平台,为尖峰药业在深耕国内市场多年的基础上进军国际市场作好准备,为未来的长远发展打下了良好的基础。
知识产权管理显特色
作为从事医药产品制造与销售的企业,具有相对较高的技术含量,尖峰药业从一开始便注重对知识产权的保护与管理,积极参与商标、专利的申报。
2008年,尖峰药业“利欧”“立肖均”两只商标被认定为金华市著名商标。2012年,“尖峰”商标成为浙江省著名商标,2016年成为“中国驰名商标”。目前,尖峰药业拥有国内、国际药品发明专利52项,2013年被认定为浙江省专利示范企业。
2015年,尖峰药业专门召开《企业知识产权管理规范》贯标启动大会,全面加强知识产权管理工作。2016年,尖峰药业通过知识产权管理体系认证;2017年4月被评为国家知识产权优势企业,得分名列金华参评企业榜首;同年12月,又被确定为国家知识产权示范企业,为金华市本级企业首家,填补金华市本级空白。
通过这一系列的知识产权管理活动,取得了优异的成果,扩大了公司的品牌影响力和社会美誉度。
热心公益担责任
作为上市公司尖峰集团的子公司,尖峰药业一直热心社会公益事业,在全力做好公司自身的质量、安全、环保本职工作之外,多次参与公益行动并进行捐赠,切实承担起了企业的社会责任。
1999年,尖峰药业捐赠3万元支援西藏那曲地区医药事业;2002年,捐赠28台近百万的制药设备给新疆墨玉县以支援当地经济建设;2003年,捐赠价值28<
More information
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-31
Jianfeng Pharmaceutical Artificial Niuhuang Project Starts
News from this newspaper Jianfeng Pharmaceutical artificial bezoar technical transformation project recently started construction in Qiubin Factory. Artificial bezoar has the effect of clearing away heat and detoxification, resolving phlegm, and is commonly used in Chinese and Western medicines such as colds, clearing away heat and detoxification. As the vast majority of artificial bezoar-related preparations are national essential drugs, with the further implementation of the medical reform policy, the downstream industry of artificial bezoar will enter a new round of business cycle. Jianfeng Pharmaceutical has many years of experience in artificial bezoar production. The technological transformation project will use the existing workshop structure, public works and operators of Qiubin Factory to achieve an annual production capacity of 100 tons of artificial bezoar by adding production equipment such as double cone rotary vacuum drying, horizontal ball mill pulverizer unit, hopper and hoist, closed screening system, and upgrading some public systems. According to the project implementation plan, the project will complete the civil engineering in May. Complete the commissioning, testing and verification of equipment and facilities in July, with trial production conditions; Strive to complete the on-site inspection of GMP certification before the end of December. At present, the factory buildings in Qiubin are vacated and the site is cleaned up. It is understood that the production of natural bezoar is very small, the price is extremely high, and the market rarely provides it. As a biochemical API, artificial bezoar has fewer manufacturers. In the past, due to relatively loose supervision, the testing methods of raw materials and finished products are relatively simple, the quality control indicators are not perfect, and the quality of products on the market is uneven. It is imperative to improve the quality standards. To this end, the State Food and Drug Administration issued the "Biochemical Drug GMP Quality Management Practice (Draft for Comment)" at the end of 2016, which was implemented in March 2017. spike medicine
2020
07-31
Recently, Jianfeng Health has been awarded a number of plaques and certificates by the Department of Science and Technology of Zhejiang Province, the people's Government of Jinhua City, and the Science and Technology Bureau of Jinhua City. They are "Zhejiang Science and Technology small and medium-sized Enterprises", "Jinhua High-tech Enterprises", "Jinhua Agricultural Science and Technology Enterprises", "Jinhua Agricultural Science and Technology Research and Development Center" and so on. According to the relevant requirements, Zhejiang science and technology-based small and medium-sized enterprises must be small and medium-sized enterprises with independent intellectual property rights, proprietary technology or advanced knowledge, engaged in the research, development, production, sales and service of high-tech and its products, and the proportion of enterprises engaged in scientific and technological research and development personnel accounting for no less than 10% of the total number of employees in that year. Since its establishment, Jianfeng Health has attached great importance to the training of scientific and technological personnel, paid attention to the application of its own intellectual property rights, paid attention to product research and development and the protection of intellectual property rights, promoted the application of intellectual property rights, and encouraged employees to invent and create. By the end of 2016, a total of 8 invention patents and 5 appearance patents had been applied, and 1 invention patent and 5 appearance patents had been obtained. High-tech enterprises in Jinhua City must meet the requirements of the ''High-tech Fields Supported by the State, ''and continue to carry out research and development and technological achievements transformation. Their main products (services) have independent intellectual property rights (authorized, registered or accepted). There are certain requirements for the proportion of R & D personnel, the proportion of R & D funds and the income of high-tech products. The acquisition of high-tech enterprises in Jinhua City has laid the foundation for the further declaration of national high-tech enterprises in the future. In the identification of agricultural science and technology enterprises in Jinhua City, the field of peak health technology belongs to the deep processing technology and equipment of agricultural products, Chinese herbal pieces and plant extracts.
2020
07-31
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-30
Peak Pharmaceutical was rated as a national intellectual property advantage enterprises
The score ranked first among Jinhua participating enterprises. A few days ago, Peak Pharmaceutical Company was rated as a national intellectual property advantage enterprise. The selection of national intellectual property advantage enterprises is organized by the State Intellectual Property Office. The purpose is to accelerate the formation of a group of Chinese intellectual property leading enterprises with independent intellectual property rights, well-known brands and international competitive advantages, and achieve the development goal of strong intellectual property enterprises. Since Jianfeng Pharmaceutical introduced the GB-T29490-2013 "Enterprise Intellectual Property Management Standard" in 2013, it has been rated as a patent demonstration enterprise in Zhejiang Province in 2013. In 2014, the "Jianfeng" trademark obtained a famous trademark in Zhejiang Province, and the first edition of the "Intellectual Property Manual" was compiled and implemented in 2015. In 2016, it passed the third-party certification of the GB-T29490-2013 "Enterprise Intellectual Property Management Standard". The "Jianfeng" trademark was rated as a well-known trademark by the State Administration of China. In the application and selection of national knowledge by superior enterprises, 52 enterprises in Zhejiang Province won this honor, ranking second in the country in number; Jianfeng Pharmaceutical ranked first among Jinhua participating enterprises. (Zhang Mingyin)
2020
07-31
Group Party Committee to determine the annual work plan
The party Committee of the group company has determined its work ideas and work plan for 2017 a few days ago, and relevant work has been arranged below. In view of the current new political and economic situation and the task of enterprise transformation and development, the general requirements of the Party Committee of the Group Company for 2017 are: to thoroughly study and implement the spirit of the Sixth Plenary Session of the 18th CPC Central Committee and the series of important speeches by General Secretary Xi Jinping, the spirit of the Seventh Party Congress of Jinhua City, to closely revolve around the center of enterprise production, operation and reform and development, and to adhere to scientific development and cross-regional development as the first priority, in order to continue to carry out the study and education of "five stars striving for innovation" and "two learning and one doing", we should highlight the main line of comprehensively and strictly administering the party according to the rules, firmly establish the political consciousness, overall situation consciousness, core consciousness and alignment consciousness of the majority of Party members and cadres, strengthen and improve the party building work in enterprises in the spirit of reform, and strive to improve the scientific, standardized and institutionalized level of Party building work in enterprises, in order to promote the scientific development of the group company, leapfrog development and harmonious development, it provides a strong political, ideological and organizational guarantee. The working idea of the Party Committee of the Group Company in 2017 is to focus on "one center", adhere to "one concept", highlight "three key points" and do a good job in "three constructions". That is: centering on the "one center" of enterprise production, operation and reform and development, we should strive to strengthen the "one concept" of "the organic unity of the party's leadership and the improvement of corporate governance"; to "thoroughly implement the main responsibility of the party committee; continue to carry out the study and education of" two learning and one doing "; and improve the system of party building work" as the "three key points", and focus on "team building and team building
2020
07-31